Hypothesis

Aging‑associated loss of hypothalamic neural stem cell (NSC)‑derived exosomes reduces cerebrospinal fluid (CSF) levels of miR‑429, which normally inhibits IKKβ translation in microglia. Consequently, microglial IKKβ/NF‑κB signaling becomes disinhibited, leading to AP‑1‑mediated repression of the GnRH promoter and systemic neuroendocrine decline.

Mechanistic Basis

• NSC exosomes deliver miR‑429 to the hypothalamus, where it binds the 3′‑UTR of IKKβ mRNA and suppresses its expression [[https://onlinelibrary.wiley.com/doi/abs/10.1155/mi/7165782|miR-429 directly targets IKKβ to suppress microglial inflammation]].
• Aging diminishes NSC exosome secretion [[https://doi.org/10.1038/nature23282|hypothalamic neural stem cells (NSCs) as aging controllers through secretion of exosomal miRNAs into cerebrospinal fluid]], lowering CSF miR‑429 and relieving translational repression of IKKβ in microglia.
• Unchecked microglial IKKβ activates the canonical NF‑κB pathway, upregulating c‑Fos/c‑Jun (AP‑1) complexes that bind the GnRH promoter and reduce transcription by ~50% [[https://pmc.ncbi.nlm.nih.gov/articles/PMC3756938/|Aging-induced hypothalamic IKKβ/NF-κB activation directly represses the GnRH promoter]].
• This cascade explains why global Nestin‑Cre IKKβ knockout improves phenotypes [[https://pmc.ncbi.nlm.nih.gov/articles/PMC3756938/|Nestin-Cre-driven IKKβ knockout, which targets neurons, glia, and progenitors simultaneously]] but does not reveal the cellular source of pathogenic signaling.

Testable Predictions

1. CSF miR‑429 declines with age – Old mice will show a significant drop in hypothalamic NSC‑exosome‑associated miR-429 levels compared with young controls.
2. Microglial‑specific IKKβ ablation preserves GnRH – Deleting IKKβ exclusively in microglia (using Cx3cr1‑CreER) will prevent age‑dependent GnRH promoter repression, even when NSC exosomes are depleted.
3. NSC exosome or miR-429 rescue normalizes microglial IKKβ – Intracerebroventricular delivery of purified NSC exosomes or synthetic miR-429 mimics to aged mice will reduce microglial IKKβ protein, lower NF‑κB target gene expression, and restore GnRH secretion.
4. Neuronal IKKβ loss is insufficient – Deleting IKKβ in GnRH neurons (using GnRH‑Cre) will not rescue the age‑related GnRH decline if microglial IKKβ remains active, indicating that microglial signaling drives the repression.

Experimental Approach

• Generate mouse models: Cx3cr1‑CreER;Ikkb^fl/fl for microglia‑specific IKKβ knockout; GnRH‑Cre;Ikkb^fl/fl for neuronal control; Nestin‑CreER;Dicer^fl/fl to impair NSC exosome biogenesis.
• Measure CSF miR-429 by qRT‑PCR across lifespan; correlate with hypothalamic IKKβ protein (Western blot) and GnRH mRNA (RNAscope).
• Pharmacologic rescue: Treat aged mice with intrathecal NSC exosomes or miR-429 liposomes; assess microglial NF‑κB activation (p‑p65 immunohistochemistry) and downstream AP‑1 binding at the GnRH promoter (ChIP‑qPCR).
• Functional readouts: Monitor LH pulsatility, serum testosterone/estradiol, and systemic aging biomarkers (frailty index, metabolic rate) to link molecular changes to phenotypic outcomes.

If the predictions hold, this model positions microglial IKKβ as the pivotal effector translating NSC exosome loss into neuroendocrine aging, bridging two previously disparate mechanisms and offering a precise target for intervention.